This trial is a Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding. Avatrombopag is designed to trigger the body to make more platelets.

USA

https://clinicaltrials.gov/ct2/show/NCT03326843?recrs=a&cond=ITP&draw=5&rank=40

Active, but not recruiting